Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Calcineurin activates cytoglobin transcription in hypoxic myocytes.

Singh S, Manda SM, Sikder D, Birrer MJ, Rothermel BA, Garry DJ, Mammen PP.

J Biol Chem. 2009 Apr 17;284(16):10409-21. doi: 10.1074/jbc.M809572200. Epub 2009 Feb 9.

3.

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.

Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, Olson EN.

J Clin Invest. 2006 Dec;116(12):3114-26. Epub 2006 Nov 9.

4.
5.

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD.

J Clin Invest. 2003 May;111(10):1475-86.

6.

Interspecies comparison of neuroglobin, cytoglobin and myoglobin: sequence evolution and candidate regulatory elements.

Wystub S, Ebner B, Fuchs C, Weich B, Burmester T, Hankeln T.

Cytogenet Genome Res. 2004;105(1):65-78.

PMID:
15218260
7.

c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.

Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD.

EMBO J. 2003 Oct 1;22(19):5079-89.

8.

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD.

Circ Res. 2004 Jan 9;94(1):110-8. Epub 2003 Dec 1.

9.

Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes.

Lim HW, New L, Han J, Molkentin JD.

J Biol Chem. 2001 May 11;276(19):15913-9. Epub 2001 Feb 22.

10.

Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.

Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F, Molkentin JD, Drexler H, Wollert KC.

Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11363-8. Epub 2002 Aug 12.

11.

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, Olson EN.

J Clin Invest. 2000 May;105(10):1395-406.

12.

ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.

Liu Q, Sargent MA, York AJ, Molkentin JD.

Circ Res. 2009 Nov 20;105(11):1110-7. doi: 10.1161/CIRCRESAHA.109.200741. Epub 2009 Oct 8.

13.

IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.

Muckenfuss H, Hamdorf M, Avots A, Sanzenbacher R, Tschulena U, Cichutek K, Flory E.

Mol Immunol. 2006 Mar;43(8):1172-82. Epub 2005 Aug 24.

PMID:
16125242
14.

Hypertrophic agonists induce the binding of c-Fos to an AP-1 site in cardiac myocytes: implications for the expression of GLUT1.

SantalucĂ­a T, Christmann M, Yacoub MH, Brand NJ.

Cardiovasc Res. 2003 Sep 1;59(3):639-48.

PMID:
14499865
15.

GnRH regulation of Jun and Atf3 requires calcium, calcineurin, and NFAT.

Binder AK, Grammer JC, Herndon MK, Stanton JD, Nilson JH.

Mol Endocrinol. 2012 May;26(5):873-86. doi: 10.1210/me.2012-1045. Epub 2012 Mar 22.

16.

Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.

Ni YG, Berenji K, Wang N, Oh M, Sachan N, Dey A, Cheng J, Lu G, Morris DJ, Castrillon DH, Gerard RD, Rothermel BA, Hill JA.

Circulation. 2006 Sep 12;114(11):1159-68. Epub 2006 Sep 4.

17.

Cdc42 is an antihypertrophic molecular switch in the mouse heart.

Maillet M, Lynch JM, Sanna B, York AJ, Zheng Y, Molkentin JD.

J Clin Invest. 2009 Oct;119(10):3079-88. doi: 10.1172/JCI37694. Epub 2009 Sep 8.

18.

Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle.

Alfieri CM, Evans-Anderson HJ, Yutzey KE.

Am J Physiol Cell Physiol. 2007 May;292(5):C1887-94. Epub 2007 Jan 17.

19.
20.

Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.

Liu Q, Wilkins BJ, Lee YJ, Ichijo H, Molkentin JD.

Mol Cell Biol. 2006 May;26(10):3785-97.

Supplemental Content

Support Center